AffaMed And Samsung Bioepis Get Chinese Nod For Trastuzumab Trial

CBC Group Collaboration Also Covers Aflibercept, Eculizumab And Ranibizumab

 
• By Dave Wallace
  
Doctor_China_Flag
The Phase III trastuzumab trial can go ahead in China • Source: Shutterstock

More from Biosimilars

More from Products